Folia Med (Plovdiv). 2025 Mar 21;67(2). doi: 10.3897/folmed.67.e145825.
ABSTRACT
Malignant pleural effusions are a common and debilitating complication of advanced malignancies, affecting approximately one million patients annually. This condition leads to significant morbidity and a decline in quality of life. Accurate diagnosis and effective management are critical yet challenging due to the overlap in biochemical markers between malignant and benign pleural effusions.
PMID:40270142 | DOI:10.3897/folmed.67.e145825
